Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies

<p>Abstract</p> <p>Background</p> <p>Xenotropic Murine Leukemia Virus-related Virus (XMRV) is a human gammaretrovirus recently identified in prostate cancer tissue and in lymphocytes of patients with chronic fatigue syndrome. To establish the etiologic role of XMRV infe...

Full description

Bibliographic Details
Main Authors: Qiu Xiaoxing, Swanson Priscilla, Luk Ka-Cheung, Tu Bailin, Villinger Francois, Das Gupta Jaydip, Silverman Robert H, Klein Eric A, Devare Sushil, Schochetman Gerald, Hackett John
Format: Article
Language:English
Published: BMC 2010-08-01
Series:Retrovirology
Online Access:http://www.retrovirology.com/content/7/1/68
_version_ 1818114507116904448
author Qiu Xiaoxing
Swanson Priscilla
Luk Ka-Cheung
Tu Bailin
Villinger Francois
Das Gupta Jaydip
Silverman Robert H
Klein Eric A
Devare Sushil
Schochetman Gerald
Hackett John
author_facet Qiu Xiaoxing
Swanson Priscilla
Luk Ka-Cheung
Tu Bailin
Villinger Francois
Das Gupta Jaydip
Silverman Robert H
Klein Eric A
Devare Sushil
Schochetman Gerald
Hackett John
author_sort Qiu Xiaoxing
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Xenotropic Murine Leukemia Virus-related Virus (XMRV) is a human gammaretrovirus recently identified in prostate cancer tissue and in lymphocytes of patients with chronic fatigue syndrome. To establish the etiologic role of XMRV infection in human disease requires large scale epidemiologic studies. Development of assays to detect XMRV-specific antibodies would greatly facilitate such studies. However, the nature and kinetics of the antibody response to XMRV infection have yet to be determined.</p> <p>Results</p> <p>Three rhesus macaques were infected with XMRV to determine the dynamics of the antibody responses elicited by infection with XMRV. All macaques developed antibodies to XMRV during the second week of infection, and the predominant responses were to the envelope protein gp70, transmembrane protein p15E, and capsid protein p30. In general, antibody responses to gp70 and p15E appeared early with higher titers than to p30, especially in the early period of seroconversion. Antibodies to gp70, p15E and p30 persisted to 158 days and were substantially boosted by re-infection, thus, were identified as useful serologic markers. Three high-throughput prototype assays were developed using recombinant proteins to detect antibodies to these viral proteins. Both gp70 and p15E prototype assays demonstrated 100% sensitivity by detecting all Western blot (WB) positive serial bleeds from the XMRV-infected macaques and good specificity (99.5-99.9%) with blood donors. Seroconversion sensitivity and specificity of the p30 prototype assay were 92% and 99.4% respectively.</p> <p>Conclusions</p> <p>This study provides the first demonstration of seroconversion patterns elicited by XMRV infection. The nature and kinetics of antibody responses to XMRV in primates were fully characterized. Moreover, key serologic markers useful for detection of XMRV infection were identified. Three prototype immunoassays were developed to detect XMRV-specific antibodies. These assays demonstrated good sensitivity and specificity; thus, they will facilitate large scale epidemiologic studies of XMRV infection in humans.</p>
first_indexed 2024-12-11T03:51:49Z
format Article
id doaj.art-5206d8b51ce840949df09a262a9a65da
institution Directory Open Access Journal
issn 1742-4690
language English
last_indexed 2024-12-11T03:51:49Z
publishDate 2010-08-01
publisher BMC
record_format Article
series Retrovirology
spelling doaj.art-5206d8b51ce840949df09a262a9a65da2022-12-22T01:21:52ZengBMCRetrovirology1742-46902010-08-01716810.1186/1742-4690-7-68Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studiesQiu XiaoxingSwanson PriscillaLuk Ka-CheungTu BailinVillinger FrancoisDas Gupta JaydipSilverman Robert HKlein Eric ADevare SushilSchochetman GeraldHackett John<p>Abstract</p> <p>Background</p> <p>Xenotropic Murine Leukemia Virus-related Virus (XMRV) is a human gammaretrovirus recently identified in prostate cancer tissue and in lymphocytes of patients with chronic fatigue syndrome. To establish the etiologic role of XMRV infection in human disease requires large scale epidemiologic studies. Development of assays to detect XMRV-specific antibodies would greatly facilitate such studies. However, the nature and kinetics of the antibody response to XMRV infection have yet to be determined.</p> <p>Results</p> <p>Three rhesus macaques were infected with XMRV to determine the dynamics of the antibody responses elicited by infection with XMRV. All macaques developed antibodies to XMRV during the second week of infection, and the predominant responses were to the envelope protein gp70, transmembrane protein p15E, and capsid protein p30. In general, antibody responses to gp70 and p15E appeared early with higher titers than to p30, especially in the early period of seroconversion. Antibodies to gp70, p15E and p30 persisted to 158 days and were substantially boosted by re-infection, thus, were identified as useful serologic markers. Three high-throughput prototype assays were developed using recombinant proteins to detect antibodies to these viral proteins. Both gp70 and p15E prototype assays demonstrated 100% sensitivity by detecting all Western blot (WB) positive serial bleeds from the XMRV-infected macaques and good specificity (99.5-99.9%) with blood donors. Seroconversion sensitivity and specificity of the p30 prototype assay were 92% and 99.4% respectively.</p> <p>Conclusions</p> <p>This study provides the first demonstration of seroconversion patterns elicited by XMRV infection. The nature and kinetics of antibody responses to XMRV in primates were fully characterized. Moreover, key serologic markers useful for detection of XMRV infection were identified. Three prototype immunoassays were developed to detect XMRV-specific antibodies. These assays demonstrated good sensitivity and specificity; thus, they will facilitate large scale epidemiologic studies of XMRV infection in humans.</p>http://www.retrovirology.com/content/7/1/68
spellingShingle Qiu Xiaoxing
Swanson Priscilla
Luk Ka-Cheung
Tu Bailin
Villinger Francois
Das Gupta Jaydip
Silverman Robert H
Klein Eric A
Devare Sushil
Schochetman Gerald
Hackett John
Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
Retrovirology
title Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
title_full Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
title_fullStr Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
title_full_unstemmed Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
title_short Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
title_sort characterization of antibodies elicited by xmrv infection and development of immunoassays useful for epidemiologic studies
url http://www.retrovirology.com/content/7/1/68
work_keys_str_mv AT qiuxiaoxing characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT swansonpriscilla characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT lukkacheung characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT tubailin characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT villingerfrancois characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT dasguptajaydip characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT silvermanroberth characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT kleinerica characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT devaresushil characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT schochetmangerald characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies
AT hackettjohn characterizationofantibodieselicitedbyxmrvinfectionanddevelopmentofimmunoassaysusefulforepidemiologicstudies